Home > Analytics > MEDICAMEN BIOTECH

MEDICAMEN BIOTECH
Intrinsic Value | Fundamental Analysis

BOM : 531146     NSE : MEDICAMEQ    
LT :  
    Long Term Analysis
Fundamentals : Average
Valuation : Bad [Stock is Expensive]
Debt : Low
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward
Pledged Shares : None or < 25%
Sep 25,2023
Price(EOD): β‚Ή 658.85
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
Pharmaceuticals & Drugs
MCap: β‚Ή 836.74 Cr
Value of β‚Ή 1 Lac invested in MEDICAMEN BIOTECH
on Sep 25,2018 (price: β‚Ή 475.90)

β‚Ή 1 L

β‚Ή 1.38 L

1W : -3.2% 1M : -9.4% 1Y : -41.7%
COMMUNITY POLL
for MEDICAMEN BIOTECH
Please provide your vote to see the results
MEDICAMEN BIOTECH is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Industry Peers & Returns1W1M1Y
MEDICAMEN BIOTECH -3.2% -9.4% -41.7%
SUN PHARMACEUTICAL INDUSTRIES -2.1% 0.6% 23.6%
DIVIS LABORATORIES -1.4% 2% 2%
CIPLA -5% -3.3% 8.7%
DR REDDYS LABORATORIES -5% -7.9% 30.8%
TORRENT PHARMACEUTICALS -2% -5.8% 22.5%
ABBOTT INDIA -2.8% -2.2% 24.5%
ZYDUS LIFESCIENCES -6.4% -6% 60.7%
ALKEM LABORATORIES -2.9% -4.3% 6.8%

FUNDAMENTAL ANALYSIS OF MEDICAMEN BIOTECH

 
Fundamentals Score
[ Q(TTM): Jun2023, Y: Mar2023
Q : Last Qtr data
Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
]


VALUATION OF MEDICAMEN BIOTECH

 
Valuation Score
[As on : Sep 25,2023 ]

Ratio Consolidated
P/E
P/B
P/S
55.24
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 15.09 Cr
[Latest Qtr - Jun2023 - Consolidated Results ]

4.31
P/B Calculated based on Book Value of Rs 193.29 Cr
[Latest Year - Mar2023 - Consolidated Results ]

5.57
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 149.72 Cr
[Latest Qtr - Jun2023 - Consolidated Results ]

Financial Ratios →

Insights πŸ’‘ There are potential 15% undervalued companies ! Discover More →

FAIR VALUE OF MEDICAMEN BIOTECH

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
384%
2540%
2540%

Insights πŸ’‘ You can learn about various Valuation techniques to calculate Intrinsic Value
with our bestselling video course Value Investing - The Ultimate Guide
Take Me There →

SHARE PRICE MOMENTUM OF MEDICAMEN BIOTECH


Insights πŸ’‘ There are 33% companies with bullish price momentum currently! Discover More →

MEDICAMEN BIOTECH vs SENSEX


Insights πŸ’‘ You can learn about Basics of Stock Marketing Investing
with our bestselling video course Stock Marketing Investing Simplified
Take Me There →

DEBT OF MEDICAMEN BIOTECH

Year Debt/Equity ratio
Standalone Consolidated
2022
2021
2020
Avg_3yrs
0.18
0.15
0.1
0.14
0.19
0.15
0.1
0.15
[Last Annual Data : Mar2023]
Financial Ratios →

PLEDGED PROMOTER SHARES OF MEDICAMEN BIOTECH

Pledged Promoter Shares
0 %
As on : Jun2023

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad
Shareholding Pattern →

QTRLY RESULTS OF MEDICAMEN BIOTECH

Consolidated Q-o-Q Y-o-Y
Revenue
Op Profit
Profit Before Tax
Profit After Tax
8.48%
7.1%
7.48%
4.7%
26.76%
22.87%
8.25%
10.04%
QtrlyTrend
8
Latest Qtr: Jun2023
Quarterly Result Analysis →

Insights πŸ’‘ MEDICAMEQ is one of the top 37% companies with good quarterly result uptrend ! Discover More →

MEDICAMEN BIOTECH related INDICES

BSE Indices1W1M1Y
S&P BSE MIDSMALLCAP -1.6% 3.3% 26.5%
S&P BSE SMALL CAP -1.9% 2.9% 27.3%
S&P BSE ALLCAP -2.2% 1.9% 13.3%
S&P BSE HEALTHCARE -3.1% -1.1% 22.6%
No NSE index found

You may also like the below Video Courses


FAQ about MEDICAMEN BIOTECH


Is MEDICAMEN BIOTECH good for long term investment?

As on Sep 25,2023, the Fundamentals of MEDICAMEN BIOTECH look Average and hence you may wait for the results to improve to invest for long term ! See Financial Performance of MEDICAMEN BIOTECH . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is MEDICAMEN BIOTECH UnderValued or OverValued?

As on Sep 25,2023, MEDICAMEN BIOTECH is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!

What is the Intrinsic Value of MEDICAMEN BIOTECH ?

As on Sep 25,2023, the Intrinsic Value of MEDICAMEN BIOTECH is Rs. 24.96 estimated based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. 136.26
Fair Value [Median EV / Sales Model] : Rs. 24.96
Fair Value [Median Price / Sales Model] : Rs. 24.96
Estimated Median Fair Value of MEDICAMEN BIOTECH : Rs. 24.96

The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.

Is MEDICAMEN BIOTECH trading at a Premium or Discount?

As on Sep 25,2023, MEDICAMEN BIOTECH is trading at a Premium of 2539% based on the estimates of Median Intrinsic Value!

SEBI Research Analyst
The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].